FP-MMP-12 inhibitor 1

N/A

Report date: 2024/10/29 16:23:29
NME

Base Information

Drug NameFP-MMP-12 inhibitor 1
Drug Alias NameFP-MMP-12 inhibitor 1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase 12 inhibitors
TargetsMatrix metalloproteinase 12
Therapy Area/IndicationsIdiopathic Pulmonary FibrosisLung Diseases, Interstitial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesForesee Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesForesee Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary FibrosisLung Diseases, Interstitial
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A